Sam Pearce stepped into the newly created position of Jazz Chief Commercial Officer in August 2024, bringing with her an established track record of effectively scaling commercial operations to achieve transformational growth and accelerate patient access to medicines across geographies. One hundred days in, Sam shares her initial experiences and vision for the future of her role and Jazz.
As we continue to advance our work in biliary tract cancer, we’re focused on reaching patients where they are, which will help inform our approach to R&D and better support patients throughout their care journeys with the resources they need. Partnering with advocacy organizations is one way to connect with patients directly, and in turn, gain insights that will enrich our efforts and help us tailor resources specifically to the needs of patient populations.
When Ed’s back pain did not subside after visits to the chiropractor and a massage therapist, his concerns grew. When new symptoms arose, Ed visited the doctor and learned he had cancer near his spine. Ed was diagnosed with small cell lung cancer (SCLC), which can be aggressive. Throughout his journey he prioritized staying positive and establishing a solid care team.